Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation
Human Milk Oligosaccharides (HMOs) have been proposed to be instrumental in building immune competence. To explore the role of HMOs in allergy prevention, twenty-one HMOs were quantified in breast milk samples and associated with sensitisation in infants. 2′-fucosyllactose (2′-FL) levels were positi...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Food and Agricultural Immunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09540105.2023.2301703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846115026766659584 |
|---|---|
| author | Sébastien Holvoet Francis Foata Sophie Nutten Ellen Ní Cléirigh Maya Shevlyakova Cheong Kwong Chung Gregory Lefevre Norbert Sprenger Tristan Bourdeau Dominique Donnicola Mario Noti Severine Combremont Aristea Binia Chiara Nembrini Mandy Vogel Wieland Kiess Carine Blanchard |
| author_facet | Sébastien Holvoet Francis Foata Sophie Nutten Ellen Ní Cléirigh Maya Shevlyakova Cheong Kwong Chung Gregory Lefevre Norbert Sprenger Tristan Bourdeau Dominique Donnicola Mario Noti Severine Combremont Aristea Binia Chiara Nembrini Mandy Vogel Wieland Kiess Carine Blanchard |
| author_sort | Sébastien Holvoet |
| collection | DOAJ |
| description | Human Milk Oligosaccharides (HMOs) have been proposed to be instrumental in building immune competence. To explore the role of HMOs in allergy prevention, twenty-one HMOs were quantified in breast milk samples and associated with sensitisation in infants. 2′-fucosyllactose (2′-FL) levels were positively associated with an increased risk of sensitisation, atopic dermatitis and recurrent skin rash. Interestingly, 2′-FL levels, ranging from 1.35 to 1.95 g/L, were associated with a higher prevalence of non-allergic and non-sensitised infants. The role of 2′-FL and lacto-N-neotetraose (LNnT) was further investigated in allergic sensitisation models in vivo. Oral administration of HMOs decreased allergic sensitisation. This was associated with gut microbiota and short-chain fatty acid (SCFA) production changes. Aligned with the clinical associations, the decreased sensitisation was not observed with lower and higher tested doses of the HMOs supporting a U-shape association between 2′-FL and LNnT levels and allergic sensitisation risk reduction in humans and mice.Trial registration: ClinicalTrials.gov identifier: NCT02550236. |
| format | Article |
| id | doaj-art-676d9ae488df4a1096975c4c838c91f4 |
| institution | Kabale University |
| issn | 0954-0105 1465-3443 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Food and Agricultural Immunology |
| spelling | doaj-art-676d9ae488df4a1096975c4c838c91f42024-12-20T03:35:56ZengTaylor & Francis GroupFood and Agricultural Immunology0954-01051465-34432024-12-0135110.1080/09540105.2023.2301703Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisationSébastien Holvoet0Francis Foata1Sophie Nutten2Ellen Ní Cléirigh3Maya Shevlyakova4Cheong Kwong Chung5Gregory Lefevre6Norbert Sprenger7Tristan Bourdeau8Dominique Donnicola9Mario Noti10Severine Combremont11Aristea Binia12Chiara Nembrini13Mandy Vogel14Wieland Kiess15Carine Blanchard16Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Health Science, Lausanne, SwitzerlandNestlé Development Centre Nutrition, Askeaton, IrelandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandFaculty of Medicine, LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, GermanyFaculty of Medicine, LIFE Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, GermanyNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, SwitzerlandHuman Milk Oligosaccharides (HMOs) have been proposed to be instrumental in building immune competence. To explore the role of HMOs in allergy prevention, twenty-one HMOs were quantified in breast milk samples and associated with sensitisation in infants. 2′-fucosyllactose (2′-FL) levels were positively associated with an increased risk of sensitisation, atopic dermatitis and recurrent skin rash. Interestingly, 2′-FL levels, ranging from 1.35 to 1.95 g/L, were associated with a higher prevalence of non-allergic and non-sensitised infants. The role of 2′-FL and lacto-N-neotetraose (LNnT) was further investigated in allergic sensitisation models in vivo. Oral administration of HMOs decreased allergic sensitisation. This was associated with gut microbiota and short-chain fatty acid (SCFA) production changes. Aligned with the clinical associations, the decreased sensitisation was not observed with lower and higher tested doses of the HMOs supporting a U-shape association between 2′-FL and LNnT levels and allergic sensitisation risk reduction in humans and mice.Trial registration: ClinicalTrials.gov identifier: NCT02550236.https://www.tandfonline.com/doi/10.1080/09540105.2023.2301703breast milkhuman milk oligosaccharidessensitisationatopic dermatitisfood allergyinfant nutrition |
| spellingShingle | Sébastien Holvoet Francis Foata Sophie Nutten Ellen Ní Cléirigh Maya Shevlyakova Cheong Kwong Chung Gregory Lefevre Norbert Sprenger Tristan Bourdeau Dominique Donnicola Mario Noti Severine Combremont Aristea Binia Chiara Nembrini Mandy Vogel Wieland Kiess Carine Blanchard Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation Food and Agricultural Immunology breast milk human milk oligosaccharides sensitisation atopic dermatitis food allergy infant nutrition |
| title | Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation |
| title_full | Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation |
| title_fullStr | Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation |
| title_full_unstemmed | Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation |
| title_short | Impact of consumption of the human milk oligosaccharides 2′-FL and LNnT on reduction of risk of allergic sensitisation |
| title_sort | impact of consumption of the human milk oligosaccharides 2 fl and lnnt on reduction of risk of allergic sensitisation |
| topic | breast milk human milk oligosaccharides sensitisation atopic dermatitis food allergy infant nutrition |
| url | https://www.tandfonline.com/doi/10.1080/09540105.2023.2301703 |
| work_keys_str_mv | AT sebastienholvoet impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT francisfoata impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT sophienutten impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT ellennicleirigh impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT mayashevlyakova impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT cheongkwongchung impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT gregorylefevre impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT norbertsprenger impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT tristanbourdeau impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT dominiquedonnicola impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT marionoti impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT severinecombremont impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT aristeabinia impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT chiaranembrini impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT mandyvogel impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT wielandkiess impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation AT carineblanchard impactofconsumptionofthehumanmilkoligosaccharides2flandlnntonreductionofriskofallergicsensitisation |